UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054635
Receipt number R000062428
Scientific Title Construction of an AI Platform for Estimating ADL (Activities of Daily Living) Risk
Date of disclosure of the study information 2024/07/15
Last modified on 2025/08/08 16:25:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Construction of an AI Platform for Estimating ADL (Activities of Daily Living) Risk

Acronym

Construction of an AI Platform for Estimating ADL Risk

Scientific Title

Construction of an AI Platform for Estimating ADL (Activities of Daily Living) Risk

Scientific Title:Acronym

Construction of an AI Platform for Estimating ADL (Activities of Daily Living) Risk

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Constructing an objective and scientific evaluation platform by applying proprietary markerless AI analysis to ADL, considering intra- and inter-individual variability.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

During the performance of each ADL task,
1. Range of motion
2. Muscle strength
3. Joint acceleration
4. Completion time

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Healthy adults
2. A person who signed informed consent

Key exclusion criteria

Participants who have following conditions were excluded from the study:
1. joint pain with and without movement
2. Musculoskeletal symptoms that impede movement
3. History of developmental and psychiatric disorders
4. History of head trauma or organic brain diseases with disturbance of consciousness
5. Pregnant or may be pregnant

Target sample size

180


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Sawamura

Organization

Hokkaido University

Division name

Rehabilitation Science

Zip code

060-0812

Address

Kita12-jo nishi5-chome Kita-ku Sapporo, Hokkaido, Japan

TEL

0117063387

Email

D.sawamura@pop.med.hokudai.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Sawamura

Organization

Faculty of Health Sciences, Hokkaido University

Division name

Rehabilitation Science

Zip code

060-0812

Address

Kita12-jo nishi5-chome Kita-ku Sapporo, Hokkaido, Japan

TEL

0117063387

Homepage URL


Email

D.sawamura@pop.med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethical review board of Faculty of Health Sciences, Hokkaido University

Address

Kita12-jo nishi5-chome Kita-ku Sapporo, Hokkaido, Japan

Tel

0117063316

Email

shomu@hs.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 08 Month 10 Day

Date of IRB

2024 Year 07 Month 03 Day

Anticipated trial start date

2024 Year 09 Month 15 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Constructing ADL Models Using Markerless AI Motion Analysis: Capturing Actual ADL from Three Directions (Front, Left, and Right). Extracting Skeletal Information by Digitizing Key Points (such as Body Orientation and Hand Position) from Collected Video Data. Automatically Detected Skeletal Information Is Transformed into 3D Coordinate Data, Enabling Calculation of Joint Angles over Time to Build an AI Motion Analysis Platform.


Management information

Registered date

2024 Year 06 Month 12 Day

Last modified on

2025 Year 08 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062428